Site Listing

Please choose the site that is most convenient for you

Study Name: An Open-label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine + Lapatinib in Patients With HER2-positive Locally Advanced or Metastatic Breast
178 locations found